β-neuraminic acid

Metabolite details

Identifier

CERZMXAJYMMUDR-YOQZMRDMSA-N

InChI Key

CERZMXAJYMMUDR-YOQZMRDMSA-N

IUPAC name

5-amino-3,5-dideoxy-D-glycero-β-D-galacto-non-2-ulopyranosonic acid

Preferred name

β-neuraminic acid

INN name

—

Synonym

—

ChEBI

CHEBI:49022

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Bioaccumulation of therapeutic drugs by human gut bacteria: cross-feeding metabolite analysis (FIA-MS) (E.rectale;S.salivarius assays)
• Changes and correlations of intestinal flora and liver metabolite profiles in mice with gallstones
• Intergenerational Association of Gut Microbiota and Metabolism between Perinatal Folic Acid Metabolism and Neural Tube Defects (Feces metabolomics)
• Mechanism of interventional effect and targets of Zhuyu Pill in regulating and suppressing colitis and cholestasis
• Metabolic disorder and intestinal microflora dysbiosis in chronic inflammatory demyelinating polyradiculoneuropathy
• Flow cytometry has a significant impact on the cellular metabolome (CE-MS assay)
• Unraveling the metabolic effects of benzophenone-3 on the endosymbiotic dinoflagellate Cladocopium goreaui

Observed in differential profiles

• G4_Eubacterium_rectale_DMSO_30_vs_G3_Eubacterium_rectale_Duloxetine_47
• Control_vs_Lithogenic_Diet
• Normal_vs_Neural_Tube_Defect
• Control_vs_ZYP_High_Dose
• CIDP_patient_vs_healthy_control
• Ctrl_vs_Ab
• Control_vs_BP3_Low_Concentration